Navigation Links
Study shows a key protein helps control blood pressure

University of Iowa researchers have shown that a protein channel helps nerve sensors in blood vessels keep blood pressure in check. Without the protein channel, known as ASIC2, the sensors are unable to send the brain the signals it needs to properly control blood pressure.

The finding, which was based in animal models, is important because it could be used to create new treatments to prevent high blood pressure (hypertension). The study results appear in the Dec. 24 print issue of the journal Neuron.

"Sensors in your body's blood vessels sense when your blood pressure goes up, for instance, when you get mad at someone," said the study's principal investigator Frank Abboud, M.D., professor of internal medicine and molecular physiology and biophysics at the University of Iowa Carver College of Medicine and director of the Cardiovascular Research Center at the University of Iowa. "These built-in sensors perceive the change and trigger a nearly instantaneous adjustment by sending signals to the brain, which in turn tells the blood vessels how to adjust.

"By knowing more about what makes these sensors -- known as baroreceptors -- malfunction, we may be able to find ways to make them work properly and prevent high blood pressure," added Abboud, who also holds the Edith King Pearson Chair in Cardiovascular Research and is emeritus head of the University of Iowa Department of Internal Medicine.

In the current study, the team showed that the ASIC2 channel was present in the nerve cells of mice blood vessels and that when the channel was defective, the nerve activity was also defective. They also created a mouse model that did not have the gene that codes for the protein channel and thus had no ASIC2 channels. These mice without ASIC2 channels had high blood pressure. The channels play a key role in the electrical activity that is needed to control blood pressure.

"The ASIC2 channel allows a current to be generated at the nerve endings in blood vessels," he said. "However, when there is no ASIC2, those nerve endings become defective and cannot produce electrical current, and the nervous system loses the ability to get the blood vessels to dilate when necessary. As a result, the vessels remain constricted and the blood pressure stays high even when it should not."

The finding builds on previous research by Abboud, University of Iowa colleagues and other investigators -- thanks in part to attention paid years earlier to an organism that may seem to have little in common with humans -- a worm. Abboud said that previous studies done in the 1990s in the worm C. elegans showed that certain mechanosensors were needed for the worm to perceive touch. When a particular gene was absent, the worm lost the function of those mechanosensors.

"On a hunch, we wondered whether similar mechanosensors were still present in humans even after years of evolution," Abboud said. "So about 10 years ago, we looked at sensors in neck blood vessels of humans since we knew that external compression, such as what a wrestler might experience while wrestling, can be a problem.

"The blood vessel sensors in the neck keep blood pressure from getting too high or too low. Based on what we saw at that time, we studied rat models and found genes coding for sensors. With this current study, we were able to expand our investigation and identify the function of the protein channel expressed by the gene," he added.

In addition to contributions from Abboud's laboratory, the current study involved the laboratories of University of Iowa faculty members Christopher Benson, M.D., associate professor of internal medicine; Mark Chapleau, Ph.D., professor of internal medicine; and Michael Welsh, M.D., Howard Hughes Medical Institute investigator and professor of internal medicine and molecular physiology and biophysics who holds the Roy J. Carver Biomedical Chair in Internal Medicine.

Addressing how many years of research had come to fruition, Abboud said, "The interdisciplinary knowledge and collaboration, clinical observation and making a leap from what we saw in a worm to what we could see in animals -- this all came together to advance our understanding of how these sensors control blood pressure."


Contact: Becky Soglin
University of Iowa

Related biology news :

1. New study finds catch shares improve consistency, not health, of fisheries
2. Michigan State University study sheds light on microscopic flower petal ridges
3. Bioengineered materials promote the growth of functional vasculature, new study shows
4. UR study reveals chemos toxicity to brain, possible treatment
5. Study shows loss of 15-42 percent of mammals in North America
6. UA-led study grapples with health effects of low-intensity warfare
7. Killer catfish? Venomous species surprisingly common, study finds
8. Berkeley Lab researchers participate in Homeland Security study of subway airflow
9. Study reveals H1N1 unexpected weakness
10. Tropical birds waited for land crossing between North and South America: UBC study
11. Studying hair of ancient Peruvians answers questions about stress
Post Your Comments:
(Date:11/11/2015)... MedNet Solutions , an innovative SaaS-based eClinical technology company that ... announce that it will be a Sponsor of the ... held November 17-19 in Hamburg , Germany.  ... iMedNet , MedNet,s easy-to-use, proven and affordable eClinical ... able to deliver time and cost savings of up to ...
(Date:11/9/2015)... 09, 2015 ... the "Global Law Enforcement Biometrics Market ... --> ) has announced the ... Biometrics Market 2015-2019" report to their ... ( ) has announced the addition ...
(Date:11/2/2015)... Calif. , Nov. 2, 2015  SRI International ... million to provide preclinical development services to the National ... contract, SRI will provide scientific expertise, modern testing and ... variety of preclinical pharmacology and toxicology studies to evaluate ... --> The PREVENT Cancer Drug Development Program ...
Breaking Biology News(10 mins):
(Date:11/30/2015)... , Nov. 30, 2015  Northwest Biotherapeutics (NASDAQ: ... DCVax® personalized immune therapies for solid tumor cancers, announced ... additional independent director, and the Company welcomes Neil ... in a recent anonymous internet report on NW Bio.  ... Linda Powers stated, "We agree with ...
(Date:11/27/2015)... , Nov. 27, 2015 /PRNewswire/--  Mallinckrodt plc ... announced today that it has closed the sale of ... to Guerbet (GBT- NYSE Euronext) in a transaction valued ... four manufacturing facilities and a total of approximately 1,000 ... the St. Louis area. This ...
(Date:11/26/2015)... CHESHAM , England , November 26, ... Lightpoint Medical, an innovative medical device company specializing in ... Euro grant from the European Commission as part of the ... enabling the company to carry out a large-scale clinical trial ... -->      (Logo: , ...
(Date:11/25/2015)... Studies reveal the differences in species of ... way for more effective treatment for one of the most ... --> --> Gum disease is ... yet relatively little was understood about the bacteria associated with ... by researchers from the WALTHAM Centre for Pet Nutrition together ...
Breaking Biology Technology: